Carlsmed (CARL) Capital Expenditures (2024 - 2026)

Carlsmed (CARL) has reported Capital Expenditures for 3 consecutive years, with $628000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Capital Expenditures rose 146.27% year-over-year to $628000.0; the trailing twelve-month figure through Jun 2026 stood at $1.1 million (up 102.68% YoY), and the FY2025 full-year result was $715000.0, up 297.22% from the prior year.
• Capital Expenditures climbed to $628000.0 in Q2 2026 per CARL's latest filing, from $127000.0 in the prior quarter.
• Across five years, Capital Expenditures topped out at $628000.0 in Q2 2026 and bottomed at $52000.0 in Q3 2024.
• Historically, Capital Expenditures has averaged $197875.0 across 3 years, with a median of $150500.0 in 2025.
• The sharpest annual moves came in 2025 and 2026: Capital Expenditures surged 205.77% in 2025, then fell 18.06% in 2026.
• Over 3 years, Capital Expenditures stood at $61000.0 in 2024, then jumped by 139.34% to $146000.0 in 2025, then jumped by 330.14% to $628000.0 in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $628000.0, $127000.0, and $146000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.